Cargando…

Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study

This study aims to investigate cholesterol metabolism in a mouse model with cystic fibrosis (CF) by the comparison of affected homozygous versus wild type (WT) mice. In particular, we evaluated the effects of a diet enriched with cholesterol in both mice groups in comparison with the normal diet. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amato, Felice, Castaldo, Alice, Castaldo, Giuseppe, Cernera, Gustavo, Corso, Gaetano, Ferrari, Eleonora, Gelzo, Monica, Monzani, Romina, Villella, Valeria Rachela, Raia, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790534/ https://www.ncbi.nlm.nih.gov/pubmed/33412572 http://dx.doi.org/10.1371/journal.pone.0245302

Ejemplares similares

Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis
por: Gelzo, Monica, et al.
Publicado: (2020)

TAS2R38 is a novel modifier gene in patients with cystic fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis
por: Villella, Valeria R., et al.
Publicado: (2019)

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease
por: Maiuri, Luigi, et al.
Publicado: (2019)

Cystic Fibrosis Patients with F508del/Minimal Function Genotype: Laboratory and Nutritional Evaluations after One Year of Elexacaftor/Tezacaftor/Ivacaftor Treatment
por: Carnovale, Vincenzo, et al.
Publicado: (2022)

Prenatal Diagnosis of Cystic Fibrosis and Hemophilia: Incidental Findings and Weak Points
por: Comegna, Marika, et al.
Publicado: (2019)

Lipidomic alterations in human saliva from cystic fibrosis patients
por: Caterino, Marianna, et al.
Publicado: (2023)

Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect
por: Villella, Valeria Rachela, et al.
Publicado: (2013)

Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease
por: Esposito, Speranza, et al.
Publicado: (2019)

Cystic Fibrosis-Screening Positive Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up Permits to Early Identify Patients with CFTR-Related Disorders
por: Castaldo, Alice, et al.
Publicado: (2020)

NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal Disorders
por: Esposito, Maria Valeria, et al.
Publicado: (2021)

Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination
por: Kleinfelder, Karina, et al.
Publicado: (2023)

Probiotics Supplements Reduce ER Stress and Gut Inflammation Associated with Gliadin Intake in a Mouse Model of Gluten Sensitivity
por: Ferrari, Eleonora, et al.
Publicado: (2021)

Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules
por: Carnovale, Vincenzo, et al.
Publicado: (2022)

Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis
por: Tosco, Antonella, et al.
Publicado: (2021)

Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers
por: Esposito, Maria Valeria, et al.
Publicado: (2020)

Molecular Analysis of Prothrombotic Gene Variants in Patients with Acute Ischemic Stroke and with Transient Ischemic Attack
por: Cernera, Gustavo, et al.
Publicado: (2021)

Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
por: Ferrari, Eleonora, et al.
Publicado: (2017)

Pseudo‐Bartter syndrome in infant with cystic fibrosis screen positive, inconclusive diagnosis: A case report
por: Sepe, Angela, et al.
Publicado: (2023)

Adiponectin Expression Is Modulated by Long-Term Physical Activity in Adult Patients Affected by Cystic Fibrosis
por: Polito, Rita, et al.
Publicado: (2019)

The Italian External Quality Assessment Program for Cystic Fibrosis Sweat Chloride Test: Does Active Participation Improve the Quality?
por: Salvatore, Marco, et al.
Publicado: (2020)

Elevated sweat chloride test: is it always cystic fibrosis?
por: Cimbalo, C., et al.
Publicado: (2021)

The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis
por: Occhigrossi, Luca, et al.
Publicado: (2023)

Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles
por: Comegna, Marika, et al.
Publicado: (2021)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease
por: Villella, Valeria R, et al.
Publicado: (2018)

An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis
por: Di Lullo, A.M., et al.
Publicado: (2017)

Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
por: Cernera, Gustavo, et al.
Publicado: (2023)

Further Findings Concerning Endothelial Damage in COVID-19 Patients
por: Gelzo, Monica, et al.
Publicado: (2021)

Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
por: Gelzo, Monica, et al.
Publicado: (2022)

Strategies for the etiological therapy of cystic fibrosis
por: Maiuri, Luigi, et al.
Publicado: (2017)

Gene Mutation in MicroRNA Target Sites of CFTR Gene: A Novel Pathogenetic Mechanism in Cystic Fibrosis?
por: Amato, Felice, et al.
Publicado: (2013)

MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity
por: Gelzo, Monica, et al.
Publicado: (2022)

A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study
por: Gelzo, Monica, et al.
Publicado: (2021)

Physical Activity Regulates TNFα and IL-6 Expression to Counteract Inflammation in Cystic Fibrosis Patients
por: Nigro, Ersilia, et al.
Publicado: (2021)

Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021)

Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis
por: Zarrilli, Federica, et al.
Publicado: (2017)

Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves?
por: Gelzo, Monica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afma4rhqg4l0l70qkkplu0cj71